Compare HYFT & STEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HYFT | STEX |
|---|---|---|
| Founded | 1983 | 2009 |
| Country | United States | United States |
| Employees | 77 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.5M | 47.5M |
| IPO Year | 2017 | 2013 |
| Metric | HYFT | STEX |
|---|---|---|
| Price | $1.16 | $0.44 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $4.33 | N/A |
| AVG Volume (30 Days) | 280.8K | ★ 921.9K |
| Earning Date | 09-14-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $18,000.00 |
| Revenue This Year | $12.86 | N/A |
| Revenue Next Year | $22.94 | $1,314.29 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.99 | $0.35 |
| 52 Week High | $3.00 | $5.26 |
| Indicator | HYFT | STEX |
|---|---|---|
| Relative Strength Index (RSI) | 36.43 | 39.36 |
| Support Level | $1.03 | N/A |
| Resistance Level | $1.46 | $1.07 |
| Average True Range (ATR) | 0.12 | 0.05 |
| MACD | -0.03 | -0.00 |
| Stochastic Oscillator | 5.61 | 33.07 |
MindWalk Holdings Corp is a Bio-Native AI company transforming drug discovery and development. Powered by patented HYFT technology and the LensAI platform, MindWalk unifies sequence, structure, function, and literature into a single computational language and closes the loop with an integrated, full-stack wet lab. The platform supports rapid epitope mapping, de novo molecular design, in silico vaccine exploration, and population-scale biologics analytics that help turn insights into validated candidates at speed.
Streamex Corp is a vertically integrated technology and infrastructure company. The Company is a technology company with two principal lines of business: (i) Tokenized Asset Finance, focused on digital asset and real-world asset tokenization via Streamex Exchange platform, and (ii) Biomedical Technology, focused on signal processing solutions in electrophysiology. The group provides institutional-grade solutions that bring traditional commodities and assets on-chain through secure, regulated, and yield-bearing financial instruments. It is committed to delivering transparent, scalable, and compliant digital asset solutions that bridge the gap between traditional finance and blockchain-enabled markets.